Keywords: Psychiatric Disorders, Psychiatric Disorders, Spectroscopy
Motivation: Recently Glx (glutamate+glutamine)/ tCr (total creatine) ratio at dorsolateral prefrontal cortex (DLPFC), target of repetitive transcranial magnetic stimulation (rTMS), has been suggested to be a biomarker in predicting efficacy of clinically standard rTMS treatment in adults with inadequately treatment responsive major depressive disorder. The improvement was assessed based upon composite Hamilton depression (HAMD) scale but a symptom-based analysis was lacking.
Goal(s): To identify HAMD components whose changes can be predicted by Glx/tCr ratio.
Approach: Glx/tCr obtained from single voxel MRS using MEGA-PRESS at 3-tesla was correlated with symptom-based components.
Results: Improvements of depression and somatic components were associated with Glx/tCr ratio.
Impact: Hamilton depression (HAMD) scale is a composite measure. Findings from this study identified specific symptom-based components of HAMD that are specifically changed depending on dorsolateral prefrontal cortex (glutamate+glutamine)/creatine ratio. This may help in mechanistic understanding of rTMS therapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords